Director, Oncology Epidemiology

Overview

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at

Data Analytics & Computational Sciences

Epidemiology

People Leader

Cambridge, Massachusetts, United States of America;
Horsham, Pennsylvania, United States of America;
Raritan, New Jersey, United States of America;
Spring House, Pennsylvania, United States of America;
Titusville, New Jersey, United States of America

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at

Johnson & Johnson Innovative Medicine is seeking a Director, Oncology Epidemiology to join our Global Epidemiology team. The preferred location for this position is either Raritan NJ, Titusville NJ, or Horsham PA. Consideration may also be given for Spring House PA, or Cambridge MA. (No fully remote option.)

The Director, Oncology Epidemiology is accountable for working independently while functioning under the supervision of more senior members of Global Epidemiology. The Director, Oncology Epidemiology is responsible for oversight of various projects and initiatives in areas of epidemiology and real-world evidence research. This includes leading research projects, drafting protocols and statistical analysis plans, overseeing the analysis of real-world data (including, but not limited to, insurance claims data, hospital billing data, EMRs, curated oncology datasets, registries) and the dissemination of scientific information through technical reports, presentations, and publications in peer-reviewed literature.

• Identify research study needs, drafting proposals and protocols, and contribute to real-world evidence (RWE) strategy and study conduct across the therapeutic area portfolio.
• Work closely in collaboration with colleagues in the Epidemiology group when defining research questions, developing epidemiological protocols, conducting analyses, and interpreting and communicating evidence to internal and external stakeholders.
• Participate in various multi-disciplinary matrix teams to address issues raised by product teams/regulatory agencies where real-world data (RWD)/RWE can inform decisions.
• Provide epidemiological and/or statistical consulting and support to compound/product teams, and disseminate technical information through reports, presentations, and publications in peer-reviewed literature as agreed by the team.
• Work within and outside of existing electronic databases to: assess feasibility of fit-for-purpose RWD; research natural history of diseases to understand background event rates in the indicated population expected with standard of care; perform statistical risk assessments; use historical clinical trial data and other data sources to contextualize potential safety issues for new medications; support benefit-risk assessments throughout the product lifecycle;
  
  design and conduct post-authorization safety activities, including rapid analytics for signal strengthening and formal required/committed evaluation studies, as part of Pharmacovigilance and Risk Management Plans.
• Be involved in supporting efforts for the Office of the Chief Medical Officer and cross-sector collaborations, as prioritized.
• Promote the use of standardized tools to support real world evidence generation across functions utilizing RWE as part of the Integrated Evidence Generation Plan.
• Keep up to date with changes in the external…